The early NPC screening test uses next-generation sequencing (NGS) technology to detect the presence of NPC-associated plasma Epstein-Barr virus (EBV) DNA. NPC patients can be identified at earlier stages, potentially resulting in improvement of morbidity and mortality.
The incidence of NPC is particularly high in southern parts of China, especially in Guandong, Guangxi and Hong Kong. Some early symptoms of NPC are non-specific - thus delaying medical consultations. 80% of the patients have advanced-stage disease already at diagnosis, where options of treatment can be limited.
Founded in 1963, The Chinese University of Hong Kong (CUHK) is a forward-looking comprehensive research university with a global vision and a mission to combine tradition with modernity, and to bring together China and the West. CUHK teachers and students hail from all around the world. Four Nobel laureates are associated with the university, and it is the only tertiary institution in Hong Kong with recipients of the Nobel Prize, Turing Award, Fields Medal and Veblen Prize sitting as faculty in residence. CUHK graduates are connected worldwide through an extensive alumni network. CUHK undertakes a wide range of research programmes in many subject areas, and strives to provide scope for all academic staff to undertake consultancy and collaborative projects with industry.